drugset / Trial / NCT03430934
Non-invasive Fluorescent Imaging System for Imaging Mohs Tumor
NaSingle-groupOpen-labelDevice feasibility
Summary
The objective of this study is to correlate traditional histological Mohs tissue mapping of a cutaneous tumor with the ICG-mapping procedure. The use of intradermal ICG in a cutaneous tumor during MMS followed by visualization using a fluorescent imaging system could allow surgeons to directly visualize, and roughly map the extent of a primary skin cancer and plan the Mohs procedure (i.e. the initial excision size and subsequent layer widths) accordingly.
Timeline
- Start
- 2018-07-01
- Primary completion
- 2019-08-01
- Completion
- 2019-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indocyanine Green | Diagnostic / imaging agent | — | — |